tiprankstipranks

David Pyott Insider Profile

4 Followers
David Pyott, COB & CEO, Director at Allergan, holds 28.04K shares in Alnylam Pharma (Ticker: ALNY), holds 49.75K shares in BioMarin Pharmaceutical (Ticker: BMRN), holds 18.68K shares in Avery Dennison (Ticker: AVY).
tipranks
David Pyott

David Pyott
Allergan (AGN)
COB & CEO, Director

Ranked #6,437 out of 97,944 Corporate Insiders

Profitable Transactions

54%
7 out of 13 Profitable Transactions

Average Return

+21.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$20M
34.58%
24.51%
20.71%
20.20%
0.00% Others
A breakdown of David Pyott's holdings

Insider Roles

Alnylam Pharma
(ALNY)
Director
Edwards Lifesciences
(EW)
Director
BioMarin Pharmaceutical
(BMRN)
Director
Avery Dennison
(AVY)
Director
+1 other positions
Roles that David Pyott holds in companies

Most Profitable Insider Trade

Stock:
Alnylam Pharma
(ALNY)
Rating:Informative Buy
Date:Oct 14, 2016 - Oct 14, 2017
Return:+248.20%
The most profitable trade made by David Pyott

David Pyott's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
AGN
Allergan
Mar 19, 2015
Uninformative Sell
$0.00
Alnylam Pharma
Jun 26, 2024
Director
Uninformative Buy
2.62M
$6.82M
BioMarin Pharmaceutical
May 23, 2024
Director
Uninformative Buy
$4.09M
Pliant Therapeutics
Director
Avery Dennison
Apr 24, 2020
Director
Uninformative Buy
152.09K
$3.99M
Edwards Lifesciences
May 13, 2014
Director
Uninformative Buy
$4.84M
List of latest transactions for each holding click on a transaction to see David Pyott's performance on stock

David Pyott insider profile FAQ

What is the percentage of profitable transactions made by David Pyott?
The percentage of profitable transactions made by David Pyott is 54%.
    What is the average return per transaction made by David Pyott?
    The average return per transaction made by David Pyott is 21.20%.
      What stocks does David Pyott hold?
      David Pyott holds: AGN, ALNY, BMRN, PLRX, AVY, EW stocks.
        What was David Pyott’s latest transaction?
        David Pyott latest transaction was an Uninformative Buy of $2.62M.
          What was David Pyott's most profitable transaction?
          David Pyott’s most profitable transaction was an Informative Buy of ALNY stock on October 14, 2016. The return on the trade was 248.20%.
            What is David Pyott's role in Allergan?
            David Pyott's role in Allergan is COB & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.